Skip to main content
SpringerLink
Log in

Male Sexual Dysfunction: Erectile Dysfunction (ED)

  • Living reference work entry
  • First Online:
Geriatric Diseases

  • 167 Accesses

Abstract

There is a worldwide increase in erectile dysfunction. The prevalence of ED increases with age. It increases by 10% per year of age; it increased from 2% in age group 18–38 years to 48% in the over 70 years and older. Organic causes account for a large proportion of erectile dysfunction in the elderly than in the young. The clinician should appreciate the sensitivity of the situation and must avoid creating any unnecessary embarrassment and anxiety. Male erectile dysfunction has a significant impact on health-related quality of life. The review discusses the prevalence and the causes followed by evaluation and clinical management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Nicholson A, Moreira ED Jr, Shirai M, Bin Mohd Thambi MI, Galsser DB. Epidemiology of erectile dysfunction in four countries: cross International study of the prevalence and correlates of erectile dysfunction. Urology 2003;61::201–6.

    Article  Google Scholar 

  2. Parazzini F, Munchini FF, Bortolotti A, Calabro A, Chatenond L, Colli E, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Uol. 2000;37:43–49.

    Article  CAS  Google Scholar 

  3. Weber MF, Smith DP, O’Connell DL, Patel M, de Souza OL, Sitas F, et al. Risk factors for erectile dysfunction in a cohort of 108477 Australian men. MJA. 2013;199(2):107–111.

    PubMed  Google Scholar 

  4. Holden C, McLachlan RI, Pitt SM, Cummg R, Wittert G, Agius PA, et al. Men in Australia: Telephone Survey (MATEeS): a national survey of the reproductive health and concerns of middle- aged and older Australian men.Lancet 2005;366:218–220.

    Article  PubMed  Google Scholar 

  5. Lavelle P. Erectile dysfunction.aBC Health & Wellbeing. http://www.abc.net.au/health/library/stories/2008/02/14/2160484.htm retrieved 8/29/2008.

  6. Chew KK, Earle CM, Stuckey BGA. Erectile dysfunction in general medical practice: prevalence and clinical correlations. Int Impot. Res. 2000;12:41–45.

    Google Scholar 

  7. O’Keefe M, Hunt DK. Assessment and treatment of impotence. N Med Clin N Am. 1995;79:415–434

    Article  Google Scholar 

  8. Buffum J. Pharmacosexology update: prescription drugs and sexual function. J Psychoactive Drugs.1986;18:97–06.

    Article  CAS  PubMed  Google Scholar 

  9. Guay AT. Erectile dysfunction-are you prepared to discuss?. Postgrad Med. 1995;97:127–143.

    CAS  PubMed  Google Scholar 

  10. Krane RJ, Goldstrin I, Saenz de Tejada I. Impotence. N Engl J Med. 1989:321:1648–1649.

    Article  CAS  PubMed  Google Scholar 

  11. Thase MG, Reynolds CF, Jennings JR. Nocturnal penile tumescence is diminished in depression in men. Biol Psychiatry. 1988;24:33–46.

    Article  CAS  PubMed  Google Scholar 

  12. Andresson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003;170(2Pt2):S6–13.

    Article  Google Scholar 

  13. Kim ED. Erectile Dysfunction Workshop. Emedicine.medscape.com/article/444220-workshop#c7.

  14. Kirby RS. Impotence: diagnosis and management of male erectile dysfunction. BMJ. 1994;308:957–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Fisher C, Gross J, Zuuch J. Cycle of penile erections synchronous with dreaming (REM) sleep. Arch Gen Psychiatry. 1953;12:29.

    Article  Google Scholar 

  16. Karacan J, Goodenough DR, Shapiro A. Erection cycle during sleep in relation to dream anxiety. Arch Gen Psychiatry. 1966;15:183.

    Article  Google Scholar 

  17. Lewis RW, Mayda J II. Diagnosis and treatment of vasculogenic impotence. Acta Chir Hung.1994;34:231–234.

    CAS  PubMed  Google Scholar 

  18. UK Patient. Erectile dysfunction.patient.info/doctor/erectile-dysfunction

  19. Ende J. Organic impotence. Chapter 187. Clinical Methods. The history, physical and laboratory examination. 3rd. Walker HK, Hall WD, Huest JW. Boston Butterworths,1990.

    Google Scholar 

  20. Priviero FB, Leite R, Webb RC, Teixeira CE. Neurophysiological basis of penile erection. Acta Pharmacol Sin. 2007;28(6):751–5.

    Article  CAS  PubMed  Google Scholar 

  21. De Busk RF, Pepine CJ, Glasser DB, Shpilsky A, De Riesthal H, Sweeney M, et al, Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol. 2004;93:147–153.

    Article  Google Scholar 

  22. Shakir SAW, Wilton LW, Bochier A. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. BMJ. 2001;322:651–652.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cheitlin MD, Hutter Am, Brindis Rg, Ganz P, Kaul S, Russell RU, et al. Use of sildenafil in patients with cardiovascular disease. J Am Coll Cardiol. 1999;33:273–282.

    Article  CAS  PubMed  Google Scholar 

  24. Kloner R, Padma-Nathan H. Erectile dysfunction in patients with coronary artery disease. Int J Impotence Res. 2005;17:209–215.

    Article  CAS  Google Scholar 

  25. Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, et al. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol 2002;168(5):2086–91.

    Article  PubMed  Google Scholar 

  26. Althof SE. Quality of life and erectile dysfunction. Urology 2002;59:803–10.

    Article  PubMed  Google Scholar 

  27. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study. BMJ 2004;328:1037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Impotence Association. Survey 1997. London: Taylor Nelson AGB Healthcare,1997.

    Google Scholar 

  29. Sexual Health. Consequences of erectile dysfunction. http://www.sexualhealthaustralia.com.au/consequences_of_ed.html. Accessed on 8 January 2017.

Download references

Author information

Authors and Affiliations

  1. Sydney Medical School (Westmead), The University of Sydney, 20 Panaview Crescent, 2151, North Rocks, NSW, Australia

    Nages Nagaratnam & Kujan Nagaratnam

  2. Rehabilitation and Aged Care Service, Blacktown-Mt Druitt Hospital, 2148, Sydney, NSW, Australia

    Gary Cheuk

Authors
  1. Nages Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kujan Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary Cheuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nages Nagaratnam .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2017). Male Sexual Dysfunction: Erectile Dysfunction (ED). In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32700-6_32-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32700-6_32-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32700-6

  • Online ISBN: 978-3-319-32700-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation